Want to join the conversation?
$UAL now expects 3Q16 consolidated passenger unit revenue to decline 5.5-6% compared to last year. The performance was primarily impacted by a strong U.S. dollar, lower surcharges, travel reductions from customers impacted by lower oil prices, competitive actions and passenger demand not growing at the same pace as industry capacity.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.